Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 27

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 27
---
 the transaction was undertaken in the ordinary course of business; • whether the transaction with the related person is proposed to be, or was, entered into on terms no less favorable to us than terms that could have been reach with an unrelated third party; • the purpose of, and the potential benefits to us of, the transaction; and • any other information regarding the related person transaction or the related person in the context of the proposed transaction that would be material to stockholders in light of the circumstances of the particular transaction. The Audit Committee reviews all relevant information available to it about the related person transaction. The Audit Committee may approve or ratify the related person transaction only if the Audit Committee determines that, under all of the circumstances, the transaction is in, or is not inconsistent with, our best interests. The Audit Committee may, in its sole discretion, impose conditions as it deems appropriate on us or the related person in connection with approval of the related person transaction. All transactions disclosed above, if any, were reviewed and approved by the Audit Committee in accordance with our related person transaction policy. INDEMNIFICATION OF OFFICERS AND DIRECTORS Our Certificate of Incorporation and our Bylaws provide that we indemnify each of our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. Further, we have entered into indemnification agreements with each of our directors and officers, and we have purchased a policy of directors’ and officers’ liability insurance that insures our directors and officers against the cost of defense, settlement, or payment of a judgment under certain circumstances. Pacira BioSciences, Inc. 2025 Proxy Statement | 37

TABLE OF CONTENTS Corporate Governance and Board Matters

Stockholder Rights Our important stockholder rights include:

| ​ |     | ​ | ​ | Each share of common stock is entitled to one vote on each matter properly brought before the Annual Meeting. | ​ |
| ​ |     | ​ | ​ | No cumulative voting—one share, one vote                                                                      | ​ |
| ​ |     | ​ | ​ | No voting rights ceilings, enhanced voting rights, voting certificates, or non-voting shares                  | ​ |
| ​ |     | ​ | ​ | Majority voting in uncontested elections                                                                      | ​ |
| ​ |     | ​ | ​ | No “poison pill”                                                                                              | ​ |
| ​ |     | ​ | ​ | No representative claim or other significant litigation rights limitations                                    | ​ |

Director Compensation NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Our board